adenocarcinoma of the pancreas
Showing 1 - 25 of 56
Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)
Not yet recruiting
- Adenocarcinoma of the Pancreas
- Valproic acid
- +4 more
-
Milano, Italy
- +4 more
Apr 6, 2023
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono
Completed
- Metastatic Pancreatic Cancer
- Adenocarcinoma of the Pancreas
- nab-paclitaxel and gemcitabine
- gemcitabine mono and nab-paclitaxel and gemcitabine
-
Weiden, GermanyKliniken Nordoberpfalz AG, Klinikum Weiden
Nov 21, 2022
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)
Active, not recruiting
- Adenocarcinoma of the Pancreas
- Durvalumab
- Radiation Therapy
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Jul 7, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Adenocarcinoma of the Pancreas, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Lyon (Pembrolizumab,
Active, not recruiting
- Adenocarcinoma of the Pancreas
- +2 more
-
Lyon, FranceCentre Léon Bérard
Mar 17, 2022
Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary Adenocarcinoma Trial in Lille (total pancreatectomy,
Recruiting
- Adenocarcinoma of the Pancreas
- +2 more
- total pancreatectomy
- intraportal islet autotransplantation
-
Lille, FranceHop Claude Huriez Chu Lille
Mar 14, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Adenocarcinoma of the Pancreas Trial in Pittsburgh (Stereotactic Body Radiation Therapy (SBRT))
Completed
- Adenocarcinoma of the Pancreas
- Stereotactic Body Radiation Therapy (SBRT)
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 27, 2021
Pancreatic Cancer, Pancreatic Tumors, Adenocarcinoma of the Pancreas Trial in Orlando (2 passes during EUS-guided fine needle
Recruiting
- Pancreatic Cancer
- +2 more
- 2 passes during EUS-guided fine needle biopsy
- 3 passes during EUS-guided fine needle biopsy
-
Orlando, FloridaOrlando Health
Sep 7, 2021
Adenocarcinoma of the Pancreas Trial in Morgantown (Hydroxychloroquine sulfate)
Recruiting
- Adenocarcinoma of the Pancreas
- Hydroxychloroquine sulfate
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Aug 2, 2021
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (drug, radiation,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- capecitabine
- +4 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- erlotinib hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Jul 29, 2020
Adenocarcinoma of the Pancreas Trial in Philadelphia (Paricalcitol, Abraxane, Gemcitabine)
Completed
- Adenocarcinoma of the Pancreas
- Paricalcitol
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 28, 2020
Adenocarcinoma of the Pancreas Trial in Ann Arbor (MK-1775, Gemcitabine, Radiation Therapy)
Completed
- Adenocarcinoma of the Pancreas
- MK-1775
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Feb 13, 2020
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer Trial in Omaha (drug, radiation, procedure)
Completed
- Adenocarcinoma of the Pancreas
- Stage III Pancreatic Cancer
- gemcitabine hydrochloride
- +6 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 9, 2019
Pancreas Cancer, Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Camden (Gemcitabine, nab-paclitaxel, CyberKnife)
Terminated
- Pancreas Cancer
- +4 more
- Gemcitabine
- +2 more
-
Camden, New JerseyMD Anderson Cancer Center at Cooper
Jul 26, 2019
Adenocarcinoma of the Pancreas, Pancreas Cancer Trial in Rochester (CCX872-B)
Withdrawn
- Adenocarcinoma of the Pancreas
- Pancreas Cancer
-
Rochester, New YorkUniversity of Rochester Medical Center
Jul 17, 2019
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- saracatinib
- +5 more
-
Scottsdale, Arizona
- +8 more
Mar 20, 2019
Adenocarcinoma of the Pancreas, Metastatic Disease Trial in Toronto (AUY922)
Terminated
- Adenocarcinoma of the Pancreas
- Metastatic Disease
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Feb 13, 2019
Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)
Completed
- Adenocarcinoma of the Pancreas
- +5 more
- eribulin mesylate
-
Toronto, Ontario, CanadaUniversity Health Network-Princess Margaret Hospital
Sep 19, 2017
Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Seattle (drug, radiation,
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- gemcitabine hydrochloride
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 13, 2017